Acquisition by Baker Bros. Advisors Lp of 11945 shares of Kodiak Sciences at 7.7488 subject to Rule 16b-3
KOD Stock | USD 6.40 0.40 5.88% |
About 62% of Kodiak Sciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Kodiak Sciences suggests that many traders are alarmed. The current market sentiment, together with Kodiak Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Kodiak Sciences stock news signals to limit their universe of possible portfolio assets.
Kodiak |
Filed transaction by Kodiak Sciences Director, 10 Percent Owner . Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Kodiak Sciences Fundamental Analysis
We analyze Kodiak Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kodiak Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kodiak Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Kodiak Sciences is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Kodiak Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kodiak Sciences stock to make a market-neutral strategy. Peer analysis of Kodiak Sciences could also be used in its relative valuation, which is a method of valuing Kodiak Sciences by comparing valuation metrics with similar companies.
Peers
Kodiak Sciences Related Equities
RVPHW | Reviva Pharmaceuticals | 25.00 | ||||
STOK | Stoke Therapeutics | 4.46 | ||||
GOSS | Gossamer Bio | 3.13 | ||||
RVPH | Reviva Pharmaceuticals | 2.72 | ||||
SPRO | Spero Therapeutics | 1.16 | ||||
SRPT | Sarepta Therapeutics | 0.87 | ||||
MDGL | Madrigal Pharmaceuticals | 1.03 | ||||
BMEA | Biomea Fusion | 1.65 | ||||
FBIOP | Fortress Biotech | 1.68 | ||||
CKPT | Checkpoint Therapeutics | 1.73 | ||||
AKRO | Akero Therapeutics | 2.31 | ||||
ASMB | Assembly Biosciences | 2.91 | ||||
CTMX | CytomX Therapeutics | 3.41 | ||||
RNAZ | Transcode Therapeutics | 6.09 | ||||
CGTX | Cognition Therapeutics | 6.49 | ||||
MBIO | Mustang Bio | 7.89 | ||||
TIL | Instil Bio | 8.74 |
Complementary Tools for Kodiak Stock analysis
When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |